Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Coronary Heart Disease

pyrrolidine dithiocarbamate has been researched along with Coronary Heart Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Coronary Heart Disease

ArticleYear
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis

2000